• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: June 13 - 17, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

June 13-17, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs6/14/11Washington, DCN/ASherburne Abbott (White House Office of Science and Technology Policy); Marcia McNutt (US Geological Survey); Cora Marrett, Machi Dilworth (National Science Foundation)International Dialogue on Women in STEM (science, technology, engineering, and math)
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs6/13/11Silver Spring, MDDeb Autor, Sandy KwederPaul Pomerantz (Drug Information Association)Global Supply Chain
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs6/13/11-6/17/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products6/13/11-6/17/11N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget6/13/11-6/17/11N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine6/13/11-6/17/11N/AN/AN/ANo Significant Meetings
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health6/13/11Silver Spring, MDN/AMark Smith (California Healthcare Foundation)Ortho Registries
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health6/15/11Washington, DCN/ASeveral Participants from Private Industry, Government, Academia, and the Health Advocacy CommunityGovernment-University-Industry Research Roundtable (GUIRR) Meeting: Charting a Return to 'Way Out There' Research and Risk-Taking at the Edges
Caroline Lewis, Acting Deputy Commissioner for Administration6/13/11-6/17/11N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs6/13/11-6/17/11N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D.,  Director, Center for Biologics Evaluation and Research6/13/11-6/17/11Geneva, SwitzerlandN/AN/AWHO Global Advisory Committee on Vaccine Safety
Meghan Scott, Acting Associate Commissioner for External Affairs6/13/11-6/17/11N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health6/13/11-6/17/11N/AN/AN/ANo Significant Meetings
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research6/13/11-6/17/11N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods6/13/11-6/17/11N/AN/AN/ANo Significant Meetings
Ralph Tyler, J.D., Chief Counsel6/13/11-6/14/11Beijing, ChinaSeveral FDA Officials and Staff MembersSeveral Participants from Private Industry, Government, Academia, and the Legal CommunityFood and Drug Law Institute (FDLI) US-China Food and Drug Law:  Ensuring Quality, Improving Safety, Expanding Access
Ralph Tyler, J.D., Chief Counsel6/15/11Beijing, ChinaChris Hickey
Michael Kravchuk
Brenda Uratani
Irene Chan
Lixia Wang
 
Peking University Faculty and Students
 
Roundtable Discussion at Peking University - Product Safety in China/Role of the FDA Office of the Chief Counsel
Ralph Tyler, J.D., Chief Counsel6/16/11Shanghai, ChinaChris Hickey
Michael Kravchuk
Irene Chan
Byungja Marciante
Charles Ahn
Yan (Helen) Xue
Min Sun
 
Forum ParticipantsAmCham Shanghai 2011 China Food Industry & Food Safety Forum
Ralph Tyler, J.D., Chief Counsel6/16/11Shanghai, ChinaChris Hickey
Michael Kravchuk
Brenda Uratani
Byungja Marciante
Charles Ahn
Yan (Helen) Xue
Min Sun
Doug Campbell
 
Meeting ParticipantsAmCham Shanghai Healthcare Committee
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs6/13/11-6/17/11N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research6/15/11Silver Spring, MDWendy Sanhai, Bob RappaportKenneth Kaitin (Tufts Center for the Study of Drug Development); Robert Dworkin (University of Rochester); John Farrar (University of Pennsylvania)1st Scientific Workshop:  Analgesic Clinical Trial Innovations, Opportunites, and Networks (ACTION)
Donald Kraemer, Acting Director, Center for Food Safety and Applied Nutrition6/14/11Colllege Park, MDRoberta Wagner, Denise Riley, Micheal Roosevelt, Mitch Cheeseman, Marleen Wekell, Susan Bernard, Marriane Solomotis, Julie Moss, Kathy Gombas, Linda Katz, Anne Crawford, William Jones, Camille Brewer, Nancy Yanish, Kelly Bunning, Felicia HogueHank Lambert, Lauren Hartman, Laura Snell (Underwriters Laboratories)Briefing and Presentation to Management Council on Underwriters Laboratories